Bicara Therapeutics (BCAX) Q2 2026 Earnings

19MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
-0.68
-0.62
-0.56
-0.5

Details

Expected EPS
-0.651538
Actual EPS
N/A
Surprise EPS
0.65
Surprise Percent
+100%

Description

Bicara Therapeutics (BCAX) will report earnings of for Q2 2026 on May 19, 2026.

0 Comments

Share your thoughts